RxDoctor Payments Data

Noam Stadlan, MD

Neurological Surgery · Skokie, ILNPI 1962478271

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 10 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Medtronic at 32.9% of the total. 2025 is the largest year on record at $189, 2.2 times the $86 reported in 2019. That places this record below the midpoint for neurological surgery clinicians in IL, where the typical reported total is $2,724.

$469in general payments, 2019–2025

Across 10 payments — averaging $46.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$154
  • Providence Medical Technology, Inc.$117
  • Medacta USA, Inc.$111
  • Globus Medical$59
  • Orthofix Medical, Inc.$28
$82,922in research payments, 2019–2025

Across 9 payments — averaging $9213.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pacira Pharmaceuticals Incorporated$79K
  • Intrinsic Therapeutics$4K

What the payments were for

  • Food & beverage$469100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$469 in reported general payments places this provider in the 25th percentile of 302 neurological surgery providers in Illinois.

See all neurological surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$518,794
Medicare patients
523
Services billed
1,615

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin287$3,625
Diclofenac Sodium140$976
Tizanidine Hcl111$901
Duloxetine Hcl45$746
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen39$548
Meloxicam132$441
Methylprednisolone51$269
Baclofen25$218
Amitriptyline Hcl24$217
Pregabalin14$163
Mupirocin16$122
Tramadol Hcl36$104
Methocarbamol13$52

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Skokie

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →